152 related articles for article (PubMed ID: 28453910)
21. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Walter RB; Alonzo TA; Gerbing RB; Ho PA; Smith FO; Raimondi SC; Hirsch BA; Gamis AS; Franklin JL; Hurwitz CA; Loken MR; Meshinchi S
J Clin Oncol; 2010 Jun; 28(17):2831-8. PubMed ID: 20421533
[TBL] [Abstract][Full Text] [Related]
22. Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia.
Perruso LL; Velloso E; Rocha V; Rego EM; Silva WF
Ann Hematol; 2024 Jun; 103(6):2033-2039. PubMed ID: 38180535
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Creutzig U; Dworzak MN; Zimmermann M; Reinhardt D; Sramkova L; Bourquin JP; Hasle H; Abrahamsson J; Kaspers G; van den Heuvel MM; Reedijk AMJ; De Moerloose B; Locatelli F; Masetti R
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598536
[TBL] [Abstract][Full Text] [Related]
24. Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Vujkovic M; Attiyeh EF; Ries RE; Goodman EK; Ding Y; Kavcic M; Alonzo TA; Wang YC; Gerbing RB; Sung L; Hirsch B; Raimondi S; Gamis AS; Meshinchi S; Aplenc R
Blood; 2017 Jun; 129(23):3051-3058. PubMed ID: 28411282
[TBL] [Abstract][Full Text] [Related]
25. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
26. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ
Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572
[TBL] [Abstract][Full Text] [Related]
27. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
28. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Tavernier E; Le QH; Elhamri M; Thomas X
Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
[TBL] [Abstract][Full Text] [Related]
29. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
Laver JH; Barredo JC; Amylon M; Schwenn M; Kurtzberg J; Camitta BM; Pullen J; Link MP; Borowitz M; Ravindranath Y; Murphy SB; Shuster J
Leukemia; 2000 Mar; 14(3):369-73. PubMed ID: 10720128
[TBL] [Abstract][Full Text] [Related]
30. Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.
Reid JH; Perissinotti AJ; Benitez L; Bixby DL; Burke P; Pettit K; Marini BL
Leuk Lymphoma; 2020 Apr; 61(4):862-868. PubMed ID: 31739707
[TBL] [Abstract][Full Text] [Related]
31. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
[TBL] [Abstract][Full Text] [Related]
32. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
[TBL] [Abstract][Full Text] [Related]
33. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
[TBL] [Abstract][Full Text] [Related]
34. Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement.
Ranta S; Palomäki M; Levinsen M; Taskinen M; Abrahamsson J; Hasle H; Jahnukainen K; Heyman M; Harila-Saari A;
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28233411
[TBL] [Abstract][Full Text] [Related]
35. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
[TBL] [Abstract][Full Text] [Related]
36. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
[TBL] [Abstract][Full Text] [Related]
37. Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
Rozovski U; Ohanian M; Ravandi F; Garcia-Manero G; Faderl S; Pierce S; Cortes J; Estrov Z
Leuk Lymphoma; 2015 May; 56(5):1392-7. PubMed ID: 25110819
[TBL] [Abstract][Full Text] [Related]
38. miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Ramamurthy R; Hughes M; Morris V; Bolouri H; Gerbing RB; Wang YC; Loken MR; Raimondi SC; Hirsch BA; Gamis AS; Oehler VG; Alonzo TA; Meshinchi S
Pediatr Blood Cancer; 2016 Dec; 63(12):2096-2103. PubMed ID: 27511899
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
40. Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study.
Yeh TC; Liang DC; Hou JY; Jaing TH; Lin DT; Yang CP; Peng CT; Hung IJ; Lin KH; Hsiao CC; Jou ST; Chiou SS; Chen JS; Wang SC; Chang TK; Wu KH; Sheen JM; Yen HJ; Chen SH; Lu MY; Li MJ; Chang TT; Huang TH; Chang YH; Chen SH; Yang YL; Chang HH; Chen BW; Lin PC; Cheng CN; Chao YH; Yang SH; Chao YY; Liu HC
Cancer; 2018 Dec; 124(23):4538-4547. PubMed ID: 30303520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
